Clinical Trial Update: Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation [NA]

View source ↗

Summary

A completed feasibility study evaluating newer breast MRI sequences (FIESTA, Vibrant-DE, IDEAL) for assessing breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | NA | Status: COMPLETED